Loading insider details...
Beta
Latest Form 4 (Jul 9, 2026): Grant/Award of 250,000 CLRB shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 9, 2026 | Cellectar Biosciences, Inc. (CLRB) | Grant/Award | 250,000 | n/a |
| May 12, 2026 | Cellectar Biosciences, Inc. (CLRB) | Purchase | 8,680 | $25.0K |
| Jul 3, 2025 | Cellectar Biosciences, Inc. (CLRB) | Purchase | 10,000 | $49.9K |
| Feb 18, 2025 | Cellectar Biosciences, Inc. (CLRB) | Grant/Award | 900,000 | n/a |
| Jun 18, 2024 | Cellectar Biosciences, Inc. (CLRB) | Grant/Award | 900,000 | n/a |
| Dec 13, 2023 | Cellectar Biosciences, Inc. (CLRB) | Grant/Award | 40,596 | n/a |
| Jan 18, 2023 | Cellectar Biosciences, Inc. (CLRB) | Grant/Award | 261,000 | n/a |
| Jan 27, 2022 | Cellectar Biosciences, Inc. (CLRB) | Grant/Award | 1,419,000 | n/a |
| Mar 5, 2021 | Cellectar Biosciences, Inc. (CLRB) | Purchase | 5,100 | $8.7K |
| Dec 28, 2020 | Cellectar Biosciences, Inc. (CLRB) | Purchase | 37,037 | $50.0K |